Opthea Ltd. ADR (OPT): Price and Financial Metrics
OPT Price/Volume Stats
| Current price | $3.28 | 52-week high | $5.45 |
| Prev. close | $3.26 | 52-week low | $1.79 |
| Day low | $3.26 | Volume | 19,600 |
| Day high | $3.37 | Avg. volume | 25,216 |
| 50-day MA | $4.18 | Dividend yield | N/A |
| 200-day MA | $3.25 | Market Cap | 191.54M |
OPT Stock Price Chart Interactive Chart >
Opthea Ltd. ADR (OPT) Company Bio
Opthea Ltd. is a clinical stage biopharmaceutical company that engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It targets to treat neovascular age-related macular degeneration (wet AMD) and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984 and is headquartered in South Yarra, Australia.
OPT Price Returns
| 1-mo | -26.46% |
| 3-mo | 14.29% |
| 6-mo | 2.50% |
| 1-year | 70.83% |
| 3-year | -52.60% |
| 5-year | N/A |
| YTD | 11.19% |
| 2023 | -44.96% |
| 2022 | -28.96% |
| 2021 | -32.72% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...